Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome

Acta Tropica

Volumn 128, Issue 1, 2013, Pages 168-170

  Stoeckle, Marcel ^a,b   Holbro, Andreas ^b   Arnold, Andreas ^b   Neumayr, Andreas ^a   Weisser, Maya ^b   Blum, Johannes ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Good syndrome; Hypogammaglobulinaemia; Leishmania infantum; Miltefosine; Mucosal leishmaniasis; Thymoma

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; IMMUNOGLOBULIN G; MEGLUMINE ANTIMONATE; MILTEFOSINE; STIBOGLUCONATE SODIUM;

DISEASE CONTROL; DISEASE TREATMENT; DRUG; IMMUNE RESPONSE; LEISHMANIASIS; TUMOR;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DNA EXTRACTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GOOD SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; INJECTION SITE PAIN; LEISHMANIA INFANTUM; LEISHMANIASIS; LYMPHOCYTOPENIA; MALE; MUCOSAL LEISHMANIASIS; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; QT PROLONGATION; RELAPSE; SIDE EFFECT; THYMOMA; TONGUE ULCER;

LEISHMANIA INFANTUM;

GOOD SYNDROME; HYPOGAMMAGLOBULINAEMIA; LEISHMANIA INFANTUM; MILTEFOSINE; MUCOSAL LEISHMANIASIS; THYMOMA;

ADMINISTRATION, ORAL; AGED; ANTIPROTOZOAL AGENTS; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEISHMANIA INFANTUM; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MOUTH MUCOSA; PHOSPHORYLCHOLINE; RECURRENCE; TREATMENT OUTCOME;

EID: 84883743412     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.07.002     Document Type: Article

References (14)

1. Aliaga L., Cobo F., Mediavilla J.D., Bravo J., Osuna A., Amador J.M., Martin-Sanchez J., Cordero E., Navarro J.M. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine 2003, 82:147-158.
2. Blum J., Lockwood D.N.J., Visser L., Harms G., Bailey M.S., Caumes E., Clerinx J., van Thiel P.P.A.M., Morizot G., Hatz C., Buffet P. Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. International Health 2012, 4:153-163.
3. Blum J.A., Hatz C.F. Treatment of cutaneous leishmaniasis in travelers 2009. Journal of Travel Medicine 2009, 16:123-131.
4. Good R.A., Maclean L.D., Varco R.L., Zak S.J. Thymic tumor and acquired agammaglobulinemia: a clinical and experimental study of the immune response. Surgery 1956, 40:1010-1017.
5. Kelesidis T., Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clinical Immunology 2010, 135:347-363.
6. Lessa H.A., Machado P., Lima F., Cruz A.A., Bacellar O., Guerreiro J., Carvalho E.M. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. The American Journal of Tropical Medicine and Hygiene 2001, 65:87-89.
7. Marfurt J., Nasereddin A., Niederwieser I., Jaffe C.L., Beck H.P., Felger I. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. Journal of Clinical Microbiology 2003, 41:3147-3153.
8. Marfurt J., Niederwieser I., Makia N.D., Beck H.P., Felger I. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagnostic Microbiology and Infectious Disease 2003, 46:115-124.
9. Neumayr A.L., Walter C., Stoeckle M., Braendle N., Glatz K., Blum J.A. Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment. Journal of Travel Medicine 2012, 19:124-126.
10. Notarangelo L.D. Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology 2010, 125:S182-S194.
11. Richter J., Hanus I., Haussinger D., Loscher T., Harms G. Mucosal Leishmania infantum infection. Parasitology Research 2011, 109:959-962.
12. Soto J., Berman J. Treatment of New World cutaneous leishmaniasis with miltefosine. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006, 100(Suppl 1):S34-S40.
13. Sundar S., Jha T.K., Thakur C.P., Bhattacharya S.K., Rai M. Oral miltefosine for the treatment of Indian visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006, 100(Suppl 1):S26-S33.
14. Tarr P.E., Sneller M.C., Mechanic L.J., Economides A., Eger C.M., Strober W., Cunningham-Rundles C., Lucey D.R. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine 2001, 80:123-133.